| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |